1.00Open1.00Pre Close0 Volume34 Open Interest30.00Strike Price0.00Turnover439.28%IV79.29%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.2317Delta0.0323Gamma17.29Leverage Ratio-0.2550Theta0.0005Rho4.01Eff Leverage0.0066Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet